Compugen Ltd. (TLV:CGEN)
573.50
-13.90 (-2.37%)
Oct 23, 2025, 3:22 PM IDT
Compugen Market Cap
Compugen has a market cap or net worth of 536.95 million as of October 23, 2025. Its market cap has decreased by -14.11% in one year.
Market Cap
536.95M
Enterprise Value
237.03M
Revenue
74.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
573.50
Market Cap Chart
Since August 11, 2000, Compugen's market cap has increased from 289.89M to 536.95M, an increase of 85.23%. That is a compound annual growth rate of 2.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 21, 2025 | 541.52M | 8.53% |
Dec 31, 2024 | 498.96M | -20.78% |
Dec 29, 2023 | 629.82M | 188.91% |
Dec 30, 2022 | 218.00M | -81.09% |
Dec 31, 2021 | 1.15B | -64.25% |
Dec 31, 2020 | 3.23B | 152.91% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 73.23B |
Danel (Adir Yeoshua) | 3.20B |
Kamada | 1.34B |
Bait Bakfar | 1.06B |
SofWave Medical | 1.03B |
BrainsWay | 1.01B |
Ilex Medical | 733.49M |
Novolog (Pharm-Up 1966) | 648.81M |